Hybrigenics Société Anonyme
Hybrigenics SA, together with its subsidiaries, operates as a biotechnology company in France. The company engages in development of biotechnology in the field of biotechnology, oncology, regenerative medicine, and anti-aging medicine. It is also involved in the development of technical solutions using adipose tissue cells and stem cells. The company is headquartered in Gallargues-le-Montueux, Fr… Read more
Hybrigenics Société Anonyme (3HB) - Total Liabilities
Latest total liabilities as of June 2025: €4.82 Million EUR
Based on the latest financial reports, Hybrigenics Société Anonyme (3HB) has total liabilities worth €4.82 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Hybrigenics Société Anonyme - Total Liabilities Trend (2016–2024)
This chart illustrates how Hybrigenics Société Anonyme's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Hybrigenics Société Anonyme Competitors by Total Liabilities
The table below lists competitors of Hybrigenics Société Anonyme ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
2G ENERGY - Dusseldorf Stock Exchang
DU:2GB
|
Germany | €103.46 Million |
|
Eros Resources Corp
OTCQB:EROSF
|
USA | $3.95 Million |
|
SHIN-ETSU CHEMICAL - Dusseldorf Stock Exchang
DU:SEH
|
Germany | €723.90 Billion |
|
Godolphin Resources Limited
PINK:GDPHF
|
USA | $208.43K |
|
PAPA JOHNS INTL
MU:PP1
|
Germany | €1.28 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Hybrigenics Société Anonyme's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 11.65 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.86 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hybrigenics Société Anonyme's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hybrigenics Société Anonyme (2016–2024)
The table below shows the annual total liabilities of Hybrigenics Société Anonyme from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €5.27 Million | -54.67% |
| 2023-12-31 | €11.63 Million | +134.04% |
| 2022-12-31 | €4.97 Million | +33.59% |
| 2021-12-31 | €3.72 Million | +145.00% |
| 2020-12-31 | €1.52 Million | +122.70% |
| 2019-12-31 | €681.70K | -74.87% |
| 2018-12-31 | €2.71 Million | -43.65% |
| 2017-12-31 | €4.81 Million | -9.17% |
| 2016-12-31 | €5.30 Million | -- |